Assess · Manage · Command
Know what you're missing as you bring your treatment to market. ElevatriOS™ is the Life Sciences Operating System for emerging biopharma, the funds that back them, and the parent companies that run them.
Illustrative data for a fictional company.
Readiness gets rebuilt for every asset, every financing, and every leadership change. Capital goes to redoing what an earlier decision locked in, and the gaps surface as audit findings and board questions at the worst possible moment.
Each function picks its own path and its own vendors, by referral and under pressure — and nobody owns the whole picture.
The person holding the launch plan leaves, or the org restructures mid-flight — and the context walks out with them.
The commercial roles that would own this arrive late, and a full-time executive hire costs more than most Series B/C budgets can absorb before there's revenue to justify it.
Commercial readiness gets rebuilt from zero at each company, under deadline pressure, instead of starting from a system that already knows the shape of the problem.
Each gate ends in a real milestone. Your workspace covers the gates you're in, and items from earlier gates stay in your tracker as you move forward.
Lead asset selected or in-licensed
IND submitted
First patient dosed in Phase 1
Phase 2 proof-of-concept readout
First patient in pivotal study
NDA or BLA submitted
Approval on the PDUFA date
First commercial sale
Items are tagged clinical, commercial, or both, so a Phase 2 company sees what applies now and what's coming. Every package includes unlimited users.
140 readiness items across 8 stage gates and 21 departments, built on the enterprise operating plan refined across two biopharma companies through commercial launch and a $1.2B exit. Every item is extensible per company, so the plan lives in the system, not in a few senior people's heads.
Company Intelligence and the Vendor Marketplace build the map of your landscape and the vendors who solve for it.
Maturity Assessments, Third Party Assessments, and the Launch Readiness Index turn that map into a 0–100 score you can track quarter over quarter.
AI Insights, the Risk Register, and the Benchmarking Center rank what's urgent, prioritized by legal and regulatory exposure and weighed against your submission, PDUFA, or launch date, not just the lowest score.
The Vendor Marketplace and Expert Advisor Network put the right vendor or a vetted fractional executive on the gap once it has an owner and a next step.
Every workstream between funding and launch, in the modules that make up Source, Score, Surface, and Staff above.
A living directory of Series A–C biopharma companies built on public SEC, ClinicalTrials.gov, and FDA data: pipeline, funding, and regulatory milestones, with updates on the companies you track.
140 stage-gated readiness items, each with an executive sponsor, workstream lead, due date, and People, Process, Budget, and Technology health. Add, rename, and reorder to fit your company.
Light, Moderate, and Comprehensive questionnaires scored 1–5 and rolled up to 0–100 per workstream. Have several people answer and compare where they disagree.
One 0–100 score per company across every gate up to the one you're working, with per-gate scores, coverage, and a quarterly trend for the board.
Reads every assessment answer and surfaces the 5–8 gaps most likely to block your next milestone, ranked by regulatory exposure and judged against your clock, each with one concrete next step.
Every category and item plotted by maturity against open risk exposure, so a weak item hiding inside a healthy average is visible at a glance.
A formal register of risks with owners, severity, mitigation plans, and remediation status, fed directly by AI Insights, third-party results, and your own team.
Send cybersecurity, AI-governance, and data-handling questionnaires to vendors, CROs, and partners by link, with no account needed on their side. Turn any answer into a task or a risk.
Biopharma service vendors mapped to the exact readiness items they solve for. Track which you use or are considering, and send RFIs and RFPs, reviewed by PharmaC3 before they go out.
A vetted bench of fractional executives across 12 functions, linked to the readiness items where they help.
My Tasks and Team Tasks with overdue and due-soon counts, created from readiness items, risks, assessment results, and calendar events, and assigned to real people.
Executive and team calendars linked to action items and risks, filtered to what your role and team give you access to.
The same readiness scores, rolled up for the people who answer to a board about more than one company.
For funds
See every portfolio company's Launch Readiness Index side by side, then drill into any one.
For parent companies
A function-by-subsidiary maturity grid shows which functions are weak everywhere and which are strong somewhere.
Illustrative data. The companies, fund and group shown are fictional.
Funds and parents see scores, gap and risk titles, owners, and dates. Assessment answers, notes, and documents stay inside each company's workspace.
No self-service sign-up. Company admins invite their own users with single-use links.
Every sign-in confirms a one-time code sent by email.
Admin, user, and investor roles, with module-level permissions per company and per person.
Row-level security in the database, plus authorization checks on every page and action.
Use PharmaC3's managed Claude connection, bring your own provider key, or turn AI off. Keys never reach the browser.
Vendors and partners answer questionnaires through a secure link.
Once a gap has an owner and a next step, our advisory network connects you to vetted fractional executives across the functions a launch actually needs, engaged for the workstream in front of you rather than as a long-term hire. PharmaC3 also runs operational-readiness and infrastructure and cybersecurity risk assessments directly.
Functions covered
Request a 60-day evaluation. We set up your workspace, take your team through a two-hour onboarding, and show you where the gaps are.
Prefer email? Write to info@pharmac3.com.